Reduction in the incidence of acute kidney injury after aortic arch surgery with low-dose atrial natriuretic peptide: A randomised controlled trial

European Journal of Anaesthesiology

Volumn 31, Issue 7, 2014, Pages 381-387

  Mori, Yosuke ^a   Kamada, Takaaki ^a   Ochiai, Ryoichi ^b  

^a Kawasaki Saiwai Hospital   (Japan)

^b TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATRIAL NATRIURETIC FACTOR ALPHA; CEFAZOLIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; FUROSEMIDE; GLUCOSE; HYPERTENSIVE FACTOR; NORADRENALIN; PLACEBO; TRANEXAMIC ACID; VANCOMYCIN; ATRIAL NATRIURETIC FACTOR;

ACUTE HEART FAILURE; ACUTE KIDNEY FAILURE; ADULT; AGED; ANESTHESIA INDUCTION; ANTIBIOTIC PROPHYLAXIS; AORTA ANEURYSM; AORTA ARCH ANEURYSM; AORTA ARCH ANOMALY; AORTIC ARCH SURGERY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP HYPOTHERMIC CIRCULATORY ARREST; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INFUSION; ELECTIVE SURGERY; FEMALE; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOTENSION; INCIDENCE; INTENSIVE CARE; INTRAOPERATIVE PERIOD; JAPAN; KIDNEY FUNCTION; LENGTH OF STAY; LOW DRUG DOSE; MALE; MEAN ARTERIAL PRESSURE; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; SURGICAL INFECTION; SURGICAL MORTALITY; URINE VOLUME; ACUTE KIDNEY INJURY; AORTIC ANEURYSM, THORACIC; ARTERIAL PRESSURE; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; VERY ELDERLY;

ACUTE KIDNEY INJURY; ADULT; AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, THORACIC; ARTERIAL PRESSURE; ATRIAL NATRIURETIC FACTOR; CIRCULATORY ARREST, DEEP HYPOTHERMIA INDUCED; DOUBLE-BLIND METHOD; HUMANS; INCIDENCE; INFUSIONS, INTRAVENOUS; JAPAN; LENGTH OF STAY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES;

EID: 84905496725     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0000000000000035     Document Type: Article

References (32)

1. Hobson CE, Yavas S, Segal MS, et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 2009; 119:2444-2453.
2. Estrera AL, Miller CC 3rd, Huynh TT, et al. Replacement of the ascending and transverse aortic arch: determinants of long-term survival. Ann Thorac Surg 2002; 74:1058-1064.
3. Augoustides JG, Pochettino A, Ochroch EA, et al. Renal dysfunction after thoracic aortic surgery requiring deep hypothermic circulatory arrest: definition, incidence, and clinical predictors. J Cardiothorac Vasc Anesth 2006; 20:673-677.
4. Arnaoutakis GJ, Bihorac A, Martin TD, et al. RIFLE criteria for acute kidney injury in aortic arch surgery. J Thorac Cardiovasc Surg 2007; 134:1554-1560.
5. Mori Y, Sato N, Kobayashi Y, et al. Acute kidney injury during aortic arch surgery under deep hypothermic circulatory arrest. J Anesth 2011; 25:799-804.
6. Safi HJ, Harlin SA, Miller CC, et al. Predictive factors for acute renal failure in thoracic and thoracoabdominal aortic aneurysm surgery. J Vasc Surg 1996; 24:338-344.
7. Gianello P, Squifflet JP, Carlier M, et al. Atrial natriuretic factor: a protective role after acute renal ischemia? Is there room for it in kidney transplantation? Transpl Int 1990; 3:41-46.
8. Conger JD, Falk SA, Hammond WS. Atrial natriuretic peptide and dopamine in established acute renal failure in the rat. Kidney Int 1991; 40:21-28.
9. Roy DR. Effect of synthetic ANP on renal and loop of Henle functions in the young rat. Am J Physiol 1986; 251:220-225.
10. Rosón MI, Toblli JE, Della Penna SL, et al. Renal protective role of atrial natriuretic peptide in acute sodium overload-induced inflammatory response. Am J Nephrol 2006; 26:590-601.
11. Sezai A, Shiono M, Orime Y, et al. Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery. Ann Thorac Surg 2000; 69:732-738.
12. Swärd K, Valsson F, Odencrants P, et al. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebocontrolled trial. Crit Care Med 2004; 32:1310-1315.
13. Sezai A, Hata M, Niino T, et al. Continuous low-dose infusion of human atrial natriuretic peptide in patients with left ventricular dysfunction undergoing coronary artery bypass grafting. J Am Coll Cardiol 2010; 55:1844-1851.
14. Ejaz AA, Martin TD, Johnson RJ, et al. Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery. J Thorac Cardiovasc Surg 2009; 138:959-964.
15. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31.
16. Horio M, Imai E, Yasuda Y, et al. Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis 2010; 56:32-38.
17. Bove T, Calabro MG, Landoni G, et al. The incidence and risk of acute renal failure after cardiac surgery. J Cardiothorac Vasc Anesth 2004; 18:442-445.
18. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339:321-328.
19. Marin-Grez M, Fleming JT, Steinhausen M. Atrial natriuretic peptide causes preglomerular vasodilatation and postglomerular vasoconstriction in rat kidney. Nature 1986; 324:473-476.
20. Rademaker MT, Richards AM. Cardiac natriuretic peptide for cardiac health. Clin Sci 2005; 108:23-36.
21. Boerrigter G, Lapp H, Burnett JC. Modulation of cGMP in heart failure: a new therapeutic paradigm. Handb Exp Pharmacol 2009; 191:485-506.
22. Bergman A, Odar-Cederlóf I, Westman L, Ohqvist G. Effects of human atrial natriuretic peptide in patients after coronary artery bypass surgery. J Cardiothorac Vasc Anesth 1996; 10:490-496.
23. Sezai A, Hata M, Niino T, et al. Influence of continuous infusion of low-dose human atrial natriuretic peptide on renal function during cardiac surgery. J Am Coll Cardiol 2009; 54:1058-1064.
24. Beaver TM, Winterstein AG, Shuster JJ, et al. Effectiveness of nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgery. Clin Cardiol 2006; 29:18-24.
25. Mentzer RM Jr, Oz MC, Sladen RN, et al., NAPA Investigators. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: the NAPA trial. J Am Coll Cardiol 2007; 49:716-726.
26. Chen HH, Sundt TM, Cook DJ, et al. Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study. Circulation 2007; 116 (11 Suppl):I134-I138.
27. Allgren RL, Marbury TC, Rahman SN, et al. Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 1997; 336:828-834.
28. Kitakaze M, Asakura M, Kim J, et al. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomized trials. Lancet 2007; 370:1483-1493.
29. Sumi K, Iida H, Yamaguchi S, et al. Human atrial natriuretic peptide prevents the increase in pulmonary artery pressure associated with aortic unclamping during abdominal aortic aneurysmectomy. J Cardiothorac Vasc Anesth 2008; 22:204-209.
30. Sezai A, Hata M, Wakui S, et al. Efficacy of continuous low-dose hANP administration in patients undergoing emergent coronary artery bypass grafting for acute coronary syndrome. Circ J 2007; 71:1401-1407.
31. Arora P, Rajagopalam S, Ranjan R, et al. Preoperative use of angiotensinconverting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol 2008; 3:1266-1273.
32. Coca SG, Jammalamadaka D, Sint K, et al. Preoperative proteinuria predicts acute kidney injury in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2012; 143:495-502.